DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1ANFARM HELLAS S.A.
03 17Accord healthcare
04 2Aspiro Pharma
05 1Aurobindo Pharma Limited
06 5Baxter Healthcare Corporation
07 1Bayer AG
08 2Be Pharma B.V.
09 1Biocon
10 4Biological E
11 4CUBIST PHARMS INC
12 2Cipla
13 1Clinigen Group
14 1DR REDDY'S LABORATORIES LTD
15 2Deva Holding AS
16 1Dr Reddy's Laboratories (Pty) Ltd
17 1Fosun Pharmaceutical
18 2Fresenius Kabi USA
19 3Hainan Poly Pharm
20 1Hameln Pharma GmbH
21 1Hangzhou Zhongmei Huadong Pharmaceutical
22 2Health Biotech
23 7Hikma Pharmaceuticals
24 4Hospira, Inc.
25 2Jiangsu Hengrui Medicine
26 1Kahma Group
27 1Kaliberr Labs
28 2LABORATORIOS NORMON SA
29 2Labatec Pharm
30 2Lorien Laboratories Sl
31 2MIP Pharma
32 2MSD Pharmaceuticals
33 1Macleods Pharmaceuticals Limited
34 2Maia Pharmaceuticals
35 2Meitheal Pharmaceuticals
36 2Melita Pharm, S.L.
37 8Merck & Co
38 2Noridem Enterprises Ltd
39 2Olon S.p.A
40 2Pfizer Inc
41 1Pharma Dynamics
42 1Qilu Pharmaceutical
43 2Reddy Pharma Iberia S.A.
44 2Reig Jofre
45 2Sagent Pharmaceuticals
46 1Sandoz B2B
47 2Tarbis Farma Sl
48 1Teva Pharmaceutical Industries
49 2Tillomed Laboratories Ltd
50 2Viatris
51 2Vocate Pharmaceuticals S.A
52 5Xellia Pharmaceuticals ApS
53 2Zentiva
54 1Zhejiang Hisun Pharmaceutical
01 2 Powder for Solution (Lyophilized Powder)
02 1Daptomycin 350Mg 1 Unit Parenteral Use
03 1Daptomycin 500Mg 10Ml 1 Units Parenteral Use
04 5INF
05 1INJ
06 6Injection
07 21Injection/Infusion Solution
08 2Lyophilizate
09 2Lyophilized Injection
10 1POI
11 4POWDER FOR SOLUTION
12 38POWDER;INTRAVENOUS
13 23Powder For Injection And Infusion Solution
14 13Powder For Solution For Injection And Infusion
15 1Powder for injection/infusion fluid, resolution
16 4SOLUTION;INTRAVENOUS
17 4Solution For Injection
18 4Vial
01 6Allowed
02 19Approved
03 7Authorised
04 24Authorized
05 1Available Dossier- US-EU-RoW
06 2Cancelled
07 8DISCN
08 10Generic
09 2Lead Market Dossiers- Filed
10 1Originator
11 4Prescription
12 33RX
13 2Suspensed
14 1Withdrawn
15 13Blank
01 1CUBACT
02 2CUBICIN
03 2CUBICIN RF
04 10Cubicin
05 1Cusyn
06 1DABUCOR 500
07 34DAPTOMYCIN
08 3DAPTOMYCIN FOR INJECTION
09 4DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
10 1DAPZURA RT
11 1Dapicub
12 2Daptomicina Accord
13 2Daptomicina Accordpharma
14 1Daptomicina Baxter
15 2Daptomicina Cipla
16 1Daptomicina Fosun Pharma
17 2Daptomicina Hikma
18 2Daptomicina Lorien
19 2Daptomicina Normon
20 2Daptomicina Tarbis
21 2Daptomicina Tillomed
22 2Daptomicina Xellia
23 2Daptomycin Accord
24 4Daptomycin Accord Healthcare
25 3Daptomycin Accordpharma
26 1Daptomycin Anfarm
27 2Daptomycin Be Pharma
28 2Daptomycin Dr. Reddys
29 1Daptomycin Equity
30 1Daptomycin Hameln
31 2Daptomycin Hikma
32 2Daptomycin Hospira
33 2Daptomycin Labatec
34 2Daptomycin Melita Pharm
35 2Daptomycin Mip
36 2Daptomycin Noridem
37 2Daptomycin Reddy
38 2Daptomycin Sala
39 2Daptomycin Zentiva
40 1Drymred 500
41 2Zepraxen
42 16Blank
01 4Canada
02 3China
03 2Denmark
04 7India
05 4Italy
06 8Malta
07 1Norway
08 7South Africa
09 28Spain
10 19Sweden
11 6Switzerland
12 2Turkey
13 42USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2019-05-01
Application Number : 208375
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2020-08-31
Application Number : 211403
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Daptomycin Reddy
Dosage Form : Injection/Infusion Solution
Dosage Strength : 350mg
Packaging :
Approval Date : 12/09/2017
Application Number : 20160601000022
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Daptomycin Reddy
Dosage Form : Injection/Infusion Solution
Dosage Strength : 500mg
Packaging :
Approval Date : 12/09/2017
Application Number : 20160601000039
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN RF
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-07-06
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-04-11
Application Number : 206077
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2017-10-20
Application Number : 209949
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2014-09-12
Application Number : 202857
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date :
Application Number : 203797
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2021-06-21
Application Number : 210282
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2021-06-21
Application Number : 210282
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2019-11-15
Application Number : 207104
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2017-09-12
Application Number : 208385
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-03-25
Application Number : 91039
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-06-05
Application Number : 205037
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-06-15
Application Number : 206005
Regulatory Info : RX
Registration Country : USA
